Search filters

List of works by Anne-Sophie Michallet

A fixed-duration, measurable residual disease-guided approach in CLL: follow-up data from the phase 2 ICLL-07 FILO trial

scientific article published on 09 November 2020

A prognostic index predicting survival in transformed Waldenström macroglobulinemia

scientific article published on 12 November 2020

A weekly regimen with dose escalation of doxorubicin for patients with advanced Hodgkin's lymphoma: results of a phase II study of the Groupe d'Etudes des Lymphomes de l'Adulte (GELA)

scientific article published on 01 April 2007

An 18F-FDG-PET maximum standardized uptake value > 10 represents a novel valid marker for discerning Richter's Syndrome.

scientific article published on 24 September 2015

Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study.

scientific article published on 9 September 2016

Autologous hematopoietic stem cell transplantation for adults with acute myeloid leukemia in complete remission: the Edouard Herriot Hospital experience

scientific article published on 01 June 2006

Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC.

scientific article published on 16 August 2013

B-cell receptor stereotypy and chronic lymphocytic leukaemia

scientific article published on 03 November 2014

Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).

scientific article published on 16 January 2015

Bruton's tyrosine kinase inhibitors: lessons learned from bench-to-bedside (first) studies

scientific article published on September 2014

Central nervous system involvement in chronic lymphocytic leukemia: uncommon manifestation with undefined therapeutic management.

scientific article

Characteristics of chronic lymphocytic leukemia patients achieving 5+ years of remission after FC-based first-line treatment: Retrospective observations from the FILO group.

scientific article

Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma

scientific article published in October 2005

Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis

scientific article published on 16 October 2006

Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma.

scientific article

Compromising the unfolded protein response induces autophagy-mediated cell death in multiple myeloma cells

scientific article

Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO)

scientific article published on 23 September 2020

Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies

scientific article published on 9 December 2014

Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma

scientific article published on 01 March 2006

Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia

scientific article published on 3 July 2015

First immunochemotherapy outcomes in elderly patients with CLL: a retrospective analysis

scientific article published on 26 February 2013

First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study.

scientific article published on 22 November 2016

First-line treatment of double- and triple-hit lymphomas: Survival and tolerance data from a retrospective multicenter French study

scientific article published on 11 December 2020

General Considerations on Treatment in Older Patients with Hematological Malignancies

High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR

scientific article published on 07 June 2020

Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group.

scientific article published on 10 March 2017

Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions.

scientific article published on 10 October 2014

Impact of chimaerism analysis and kinetics on allogeneic haematopoietic stem cell transplantation outcome after conventional and reduced-intensity conditioning regimens

scientific article published in March 2005

Impact of dose intensity on outcome of fludarabine, cyclophosphamide, and rituximab regimen given in the first-line therapy for chronic lymphocytic leukemia ⬇️

scientific article published on October 12, 2012

Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia

scientific article published on 29 January 2020

Long-term persistent lymphopenia in hematopoietic stem cell donors after donation for donor lymphocyte infusion

scientific article published on 01 November 2004

Maintenance therapy in diffuse large B-cell lymphoma ⬇️

scientific article published on September 1, 2012

Maintenance therapy in follicular lymphoma ⬇️

scientific article published on September 1, 2011

Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients.

scientific article

Management of elderly patients with chronic lymphocytic leukemia in the era of targeted therapies

scientific article published on September 2015

Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association

scientific article published on 06 October 2016

Obinutuzumab and ibrutinib induction therapy followed by a minimal residual disease-driven strategy in patients with chronic lymphocytic leukaemia (ICLL07 FILO): a single-arm, multicentre, phase 2 trial

scientific article published on 16 July 2019

Optimizing management of tumor lysis syndrome in adults with hematologic malignancies

scientific article published on April 2005

Overall survival benefit of symptom monitoring in real-world patients with chronic lymphocytic leukaemia treated with ibrutinib: a FiLO group study

scientific article published on 22 June 2020

Pattern of Care and Outcomes of Adolescent and Young Adults with Lymphoma Treated in the Rhône-Alpes Region

scientific article published on 14 August 2019

Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis

scientific article

Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index

scientific article published on 27 February 2010

Platinum and high-dose cytarabine-based regimens are efficient in ultra high/high-risk chronic lymphocytic leukemia and Richter's syndrome: results of a French retrospective multicenter study

scientific article published on 21 January 2015

Pregnancy and multiple myeloma are not antinomic.

scientific article

Pretreatment levels of vascular endothelial growth factor in plasma predict a complete remission rate and time to relapse or progression in patients with diffuse large B-cell lymphoma

scientific article published on 3 January 2013

Prevalence of BTK and PLCG2 mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group study

scientific article published on 26 June 2019

Real-world results of ibrutinib in relapsed/refractory CLL in France: Early results on a large series of 428 patients.

scientific article published on 25 April 2017

Recent developments in the treatment of aggressive non-Hodgkin lymphoma

scientific article published on 11 July 2008

Retreatment with rituximab in 178 patients with relapsed and refractory B-cell lymphomas: a single institution case control study

scientific article published on 01 March 2010

Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study

scientific article published on 20 December 2017

Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study

scientific article

Rituximab-cyclophosphamide-dexamethasone is highly effective in patients with monoclonal Ig deposit-related glomerulopathy and indolent non-Hodgkin lymphomas

scientific article published on 30 July 2014

Rituximab–cyclophosphamide–dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia ⬇️

scientific article published on July 1, 2011

Role of early PET in the management of diffuse large B-cell lymphoma.

scientific article published on September 2010

Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial

scientific article

Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: the French intergroup experience

scientific article published on 01 April 2015

Sequential combination of gemcitabine, vinorelbine, pegylated liposomal doxorubicin and brentuximab as a bridge regimen to transplant in relapsed or refractory Hodgkin lymphoma

scientific article published on 3 April 2015

Sequential combination of high dose methotrexate and L-asparaginase followed by allogeneic transplant: a first-line strategy for CD4+/CD56+ hematodermic neoplasm

scientific article published on 16 March 2012

The ibrutinib B-cell proliferation inhibition is potentiated in vitro by dexamethasone: Application to chronic lymphocytic leukemia.

scientific article published on 10 May 2016

Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO).

scientific article

Transplant Outcome of Unrelated Hematopoietic Stem Cell Transplantation (HSCT) after Myelo-Ablative or Reduced Intensity Conditioning (RIC) for Chronic Lymphocytic Leukemia(CLL). A Study of EBMT Registry

scientific article

Paulina is supported by:

About Paulina

Help